The bill would require MassHealth to cover FDA-approved anti-obesity medications (including Wegovy, Saxenda, and Zepbound) for any enrollee with: BMI 30, or BMI 27 with at least one weight-related comorbidity The bill includes a fiscal note estimating first-year cost of $680 million, assuming 6% uptake among eligible enrollees
Scrolling through YouTube and TikTok, I noticed a pattern
We can modify or cancel an order only if it hasnt been processed or shipped
By supporting collagen production and cellular repair, it helps protect the skin from oxidative damage caused by UV rays and pollution
Related Reading Tirzepatide Vs Semaglutide Side Effects Semaglutide Side Effects Medvi Semaglutide Bioverse Semaglutide Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims